David Ranganathan PHD

Director, CMC and cGMP IND Manufacturing


Dr. Ranganathan joined the RadioMedix in 2012 and currently serves as Director for CMC and Regulatory Affairs. Extensive experience in translational oncology research, managing CMOs/CROs and clinical drug development for several agents. Authored CMC sections and managed regulatory submissions to FDA and other health authorities to support 8 INDs and 1 NDA to date. Hands on experience in setting up and managing a Radiopharmaceutical manufacturing facility and also led multiple tech transfer programs which have translated into clinical trial supply. He has been a co-author on several scientific articles for peer-reviewed journals and conference papers. He received a M.Sc. in chemistry from University of Madras, a PhD in Chemical sciences from University of Camerino, and completed a postdoctoral fellowship in Radiological Sciences at Washington University School of Medicine in Saint Louis.